← SynDRA
WAY-181187
SynDRA canonical compound SYN1954305 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HTR2A |
|---|
| Mechanism of action | serotonin receptor agonist |
|---|
| Indication | depression |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- serotonin receptor agonist
- HTR6 MODULATOR
Cross-references
Synonyms
- WAY 181187
- UNII-WXE3H7W295
- WXE3H7W295
- WAY-181,187
- SCHEMBL801436
- WAY181187 HCl
- GTPL3240
- CHEMBL392760
- BDBM21358
- SAX-187
- DTXSID50204011
- EX-A799
- MolPort-005-933-335
- ZINC3816551
- AKOS028111927
- WAY-181187(SAX-187)
- KB-81479
- FT-0700331
- WAY181187.HCl pound WAY-181 187 pound(c)
- J-690323
- N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine
- 1-[(6-chloroimidazo[2,1-b]thiazol-5-yl)sulfonyl]-1H-indole-3-ethanamine
Look up WAY-181187 in the interactive SynDRA portal →